Eosinophilic Esophagitis in a Developing Country: Is It Different from Developed Countries?

Background and Objective. Despite the extensive reporting of eosinophilic esophagitis (EoE) from industrialized developed countries, reports from developing countries are rare. The aim of our study was to determine the epidemiological, clinical, and endoscopic features of EoE and response to therapy...

Full description

Saved in:
Bibliographic Details
Main Authors: Abdulrahman Al-Hussaini, Toufic Semaan, Imad El Hag
Format: Article
Language:English
Published: Wiley 2013-01-01
Series:Gastroenterology Research and Practice
Online Access:http://dx.doi.org/10.1155/2013/526037
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832568076290228224
author Abdulrahman Al-Hussaini
Toufic Semaan
Imad El Hag
author_facet Abdulrahman Al-Hussaini
Toufic Semaan
Imad El Hag
author_sort Abdulrahman Al-Hussaini
collection DOAJ
description Background and Objective. Despite the extensive reporting of eosinophilic esophagitis (EoE) from industrialized developed countries, reports from developing countries are rare. The aim of our study was to determine the epidemiological, clinical, and endoscopic features of EoE and response to therapy in children and adults from a developing country, Saudi Arabia. Methods. We identified patients diagnosed with EoE in our center from 2004 to 2011. EoE was defined as esophageal mucosal infiltration with a peak eosinophil count ≥15 eosinophils/high-powered field. Results. Forty-five patients were diagnosed with EoE (37 children and 8 adults; 36 males; median age 10.5 years, range from 1–37 years). Feeding difficulty, vomiting/regurgitation, and failure to thrive predominated in young children, whereas dysphagia and food impactions predominated in older children and adults. Allergy testing revealed food sensitization in 12 of 15 patients (80%); 3 responded to elemental formula, while 8 failed to respond to dietary manipulation after the allergy testing. Thirty-nine patients achieved remission by swallowed inhaled fluticasone. The majority of patients experienced a recurrence of symptoms upon the discontinuation of fluticasone. Conclusion. Our data indicate that EoE is increasingly recognized in Saudi Arabia and show many similarities to data from North America and Europe.
format Article
id doaj-art-54c5567374c64d7f919ce7f49172c285
institution Kabale University
issn 1687-6121
1687-630X
language English
publishDate 2013-01-01
publisher Wiley
record_format Article
series Gastroenterology Research and Practice
spelling doaj-art-54c5567374c64d7f919ce7f49172c2852025-02-03T00:59:51ZengWileyGastroenterology Research and Practice1687-61211687-630X2013-01-01201310.1155/2013/526037526037Eosinophilic Esophagitis in a Developing Country: Is It Different from Developed Countries?Abdulrahman Al-Hussaini0Toufic Semaan1Imad El Hag2University of King Saud bin Abdulaziz for Health Sciences, Children's Hospital, King Fahad Medical City, P.O. Box 59046, Riyadh, Saudi ArabiaDepartment of Medicine, King Saud Medical City, P.O. Box 7855, Riyadh, Saudi ArabiaDepartment of Pathology, Prince Sultan Medical City, P.O. Box 7855, Riyadh 111107, Saudi ArabiaBackground and Objective. Despite the extensive reporting of eosinophilic esophagitis (EoE) from industrialized developed countries, reports from developing countries are rare. The aim of our study was to determine the epidemiological, clinical, and endoscopic features of EoE and response to therapy in children and adults from a developing country, Saudi Arabia. Methods. We identified patients diagnosed with EoE in our center from 2004 to 2011. EoE was defined as esophageal mucosal infiltration with a peak eosinophil count ≥15 eosinophils/high-powered field. Results. Forty-five patients were diagnosed with EoE (37 children and 8 adults; 36 males; median age 10.5 years, range from 1–37 years). Feeding difficulty, vomiting/regurgitation, and failure to thrive predominated in young children, whereas dysphagia and food impactions predominated in older children and adults. Allergy testing revealed food sensitization in 12 of 15 patients (80%); 3 responded to elemental formula, while 8 failed to respond to dietary manipulation after the allergy testing. Thirty-nine patients achieved remission by swallowed inhaled fluticasone. The majority of patients experienced a recurrence of symptoms upon the discontinuation of fluticasone. Conclusion. Our data indicate that EoE is increasingly recognized in Saudi Arabia and show many similarities to data from North America and Europe.http://dx.doi.org/10.1155/2013/526037
spellingShingle Abdulrahman Al-Hussaini
Toufic Semaan
Imad El Hag
Eosinophilic Esophagitis in a Developing Country: Is It Different from Developed Countries?
Gastroenterology Research and Practice
title Eosinophilic Esophagitis in a Developing Country: Is It Different from Developed Countries?
title_full Eosinophilic Esophagitis in a Developing Country: Is It Different from Developed Countries?
title_fullStr Eosinophilic Esophagitis in a Developing Country: Is It Different from Developed Countries?
title_full_unstemmed Eosinophilic Esophagitis in a Developing Country: Is It Different from Developed Countries?
title_short Eosinophilic Esophagitis in a Developing Country: Is It Different from Developed Countries?
title_sort eosinophilic esophagitis in a developing country is it different from developed countries
url http://dx.doi.org/10.1155/2013/526037
work_keys_str_mv AT abdulrahmanalhussaini eosinophilicesophagitisinadevelopingcountryisitdifferentfromdevelopedcountries
AT touficsemaan eosinophilicesophagitisinadevelopingcountryisitdifferentfromdevelopedcountries
AT imadelhag eosinophilicesophagitisinadevelopingcountryisitdifferentfromdevelopedcountries